Literature DB >> 9705485

Requirement of protein synthesis for group I mGluR-mediated induction of epileptiform discharges.

L R Merlin1, P J Bergold, R K Wong.   

Abstract

Picrotoxin (50 microM) elicited rhythmic synchronized bursting in CA3 pyramidal cells in guinea pig hippocampal slices. Addition of the selective group I metabotropic glutamate receptor (mGluR) agonist (S)-3,5-dihydroxyphenylglycine (25 microM) elicited an increase in burst frequency. This was soon followed by a slowly progressive increase in burst duration (BD), converting the brief 250-520 ms picrotoxin-induced synchronized bursts into prolonged discharges of 1-5 s in duration. BD was significantly increased within 60 min and reached a maximum after 2-2.5 h of agonist exposure. The protein synthesis inhibitors anisomycin (15 microM) or cycloheximide (25 microM) significantly impeded the mGluR-mediated development of the prolonged bursts; 90-120 min of agonist application failed to elicit the expected burst prolongation. By contrast, the mGluR-mediated enhancement of burst frequency progressed unimpeded. Furthermore, protein synthesis inhibitors had no significant effect on the frequency or duration of fully developed mGluR-induced prolonged discharges. These results suggest that the group I mGluR-mediated prolongation of synchronized bursts has a protein synthesis-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9705485     DOI: 10.1152/jn.1998.80.2.989

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  40 in total

1.  Group I metabotropic glutamate receptors elicit epileptiform discharges in the hippocampus through PLCbeta1 signaling.

Authors:  S C Chuang; R Bianchi; D Kim; H S Shin; R K Wong
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

2.  A receptor for activated C kinase is part of messenger ribonucleoprotein complexes associated with polyA-mRNAs in neurons.

Authors:  Frank Angenstein; Anne M Evans; Robert E Settlage; Stewart T Moran; Shuo-Chien Ling; Anna Y Klintsova; Jeffrey Shabanowitz; Donald F Hunt; William T Greenough
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

3.  Distinctions between persistent and reversible group I mGluR-induced epileptiform burst prolongation.

Authors:  Michaelangelo G Fuortes; Marjorie J Rico; Lisa R Merlin
Journal:  Epilepsia       Date:  2010-08       Impact factor: 5.864

4.  Brain Cytoplasmic 1 RNA: Little Guy with a Big Role as a Repressor of Epileptogenesis.

Authors:  Lisa R Merlin
Journal:  Epilepsy Curr       Date:  2010-05       Impact factor: 7.500

5.  Group I mGluR-induced epileptogenesis: distinct and overlapping roles of mGluR1 and mGluR5 and implications for antiepileptic drug design.

Authors:  Robert K S Wong; Riccardo Bianchi; Shih-Chieh Chuang; Lisa R Merlin
Journal:  Epilepsy Curr       Date:  2005 Mar-Apr       Impact factor: 7.500

Review 6.  Toward fulfilling the promise of molecular medicine in fragile X syndrome.

Authors:  Dilja D Krueger; Mark F Bear
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

Review 7.  The state of synapses in fragile X syndrome.

Authors:  Brad E Pfeiffer; Kimberly M Huber
Journal:  Neuroscientist       Date:  2009-03-26       Impact factor: 7.519

8.  Impaired activity-dependent FMRP translation and enhanced mGluR-dependent LTD in Fragile X premutation mice.

Authors:  Adam J Iliff; Abigail J Renoux; Amy Krans; Karen Usdin; Michael A Sutton; Peter K Todd
Journal:  Hum Mol Genet       Date:  2012-12-18       Impact factor: 6.150

9.  Cellular plasticity for group I mGluR-mediated epileptogenesis.

Authors:  Riccardo Bianchi; Shih-Chieh Chuang; Wangfa Zhao; Steven R Young; Robert K S Wong
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

Review 10.  Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome.

Authors:  Gül Dölen; Mark F Bear
Journal:  J Physiol       Date:  2008-01-17       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.